scispace - formally typeset
J

John S. Lowe

Researcher at Vanderbilt University

Publications -  8
Citations -  1640

John S. Lowe is an academic researcher from Vanderbilt University. The author has contributed to research in topics: NAV1.5 Voltage-Gated Sodium Channel & Sodium channel. The author has an hindex of 8, co-authored 8 publications receiving 1494 citations. Previous affiliations of John S. Lowe include University of Iowa & Roy J. and Lucille A. Carver College of Medicine.

Papers
More filters
Journal ArticleDOI

A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation

TL;DR: It is shown that oxidation of paired regulatory domain methionine residues sustains CaMKII activity in the absence of Ca2+/CaM and highlights the critical importance of oxidation-dependent CaMK II activation to AngII and ischemic myocardial apoptosis.
Journal ArticleDOI

Defining the Cellular Phenotype of “Ankyrin-B Syndrome” Variants Human ANK2 Variants Associated With Clinical Phenotypes Display a Spectrum of Activities in Cardiomyocytes

TL;DR: These data identify ANK2 variants as modulators of human arrhythmias, provide the first insight into the clinical spectrum of “ankyrin-B syndrome,” and reinforce the role of ankyrIn-B–dependent protein interactions in regulating cardiac electrogenesis.
Journal ArticleDOI

Voltage-gated Nav channel targeting in the heart requires an ankyrin-G–dependent cellular pathway

TL;DR: This data are the first report of a cellular pathway required for Nav channel trafficking in the heart and suggest that ankyrin-G is critical for cardiac depolarization and Nav channel organization in multiple excitable tissues.
Journal ArticleDOI

Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro.

TL;DR: Although D1275N produces near-normal currents in multiple heterologous expression experiments, the data establish this variant as a pathological mutation that generates conduction slowing, arrhythmias, and a dilated cardiomyopathy phenotype by reducing cardiac sodium current.